More about

Non-Clear Cell Renal Cell Carcinoma

News
November 11, 2023
4 min read
Save

Heterogeneity in germline susceptibility to renal cell carcinoma has genetic screening implications

Heterogeneity in germline susceptibility to renal cell carcinoma has genetic screening implications

NASHVILLE, Tenn. — An analysis of germline susceptibility to renal cell carcinoma revealed considerable heterogeneity, according to findings presented at International Kidney Cancer Symposium: North America.

News
November 07, 2023
1 min watch
Save

VIDEO: Trial explores novel TKI plus PD-1 inhibitor for non-clear cell renal cell carcinoma

VIDEO: Trial explores novel TKI plus PD-1 inhibitor for non-clear cell renal cell carcinoma

MADRID — In a video interview with Healio, Sumanta (Monty) Pal, MD, FASCO, spoke about the STELLAR-304 clinical trial for patients with non-clear cell renal cell carcinoma at ESMO Congress.